Advertisement

Japanese Journal of Ophthalmology

, Volume 59, Issue 2, pp 131–134 | Cite as

Virological and molecular biological evidence supporting herpes simplex virus type 1 corneal latency

  • Shiro HigakiEmail author
  • Masahiko Fukuda
  • Yoshikazu Shimomura
Clinical Investigation

Abstract

Purpose

Trigeminal and other ganglia are known as sites of latent infection by herpes simplex virus type 1 (HSV-1). In ophthalmology, HSV-1 remains latent in the trigeminal ganglia, and becomes reactivated by several factors, including stress, thermal stimulation, or immunosuppression, and may lead to herpetic keratitis. The purpose of this study was to demonstrate HSV corneal latent infection using molecular biology and virology techniques.

Methods

Six corneas obtained at penetrating keratoplasty were snap-frozen; three of them were with past history of herpetic keratitis. TaqMan Real-time PCR was used to show positive HSV DNA in the corneas. We proved negative homogenate and positive explant virologically. Using real-time RT-PCR, we showed that only latency-associated transcript (LAT) was detected and no transcriptional products of other virus genes (α, β, γ) were detected.

Results

All three corneas with past history of herpetic keratitis had HSV DNA and showed negative homogenate and positive explant. LAT was detected in all three corneas. However, α, β, or γ genes were not expressed. All the results of these corneas were consistent with the conditions of corneal latency. The other three corneas without history of herpetic keratitis showed negative homogenate and negative explant. None of them had LAT.

Conclusion

We have shown a possibility that HSV can latently infect the cornea aside from the ganglion.

Keywords

HSV-1 Latency Cornea LAT 

Notes

Acknowledgements

This study was supported by the Michiko Kihara Ophthalmic Medical Fund of the Osaka Community Foundation. The authors wish to thank Mrs. Yukiko Mimuro for the editing of this manuscript and Mrs. Mayumi Mizuno for her technical assistance.

Conflicts of interest

S. Higaki, None; M. Fukuda, None; Y. Shimomura, None.

References

  1. 1.
    Stevens JG. Human herpesvirus: a consideration of the latent state. Microbiol Rev. 1989;53:318–32.PubMedCentralPubMedGoogle Scholar
  2. 2.
    Sawtell NM, Thompson RL. Rapid in vivo reactivation of herpes simplex virus in latently infected murine ganglionic neurons after transient hyperthermia. J Virol. 1992;66:2150–6.PubMedCentralPubMedGoogle Scholar
  3. 3.
    Haruta Y, Rootman DS, Hill JM. Recurrent HSV-1 corneal lesions in rabbits induced by cyclophosphamide and dexamethasone. Invest Ophthalmol Vis Sci. 1989;30:371–6.PubMedGoogle Scholar
  4. 4.
    Richter ER, Dias JK, Gilbert JE, et al. Distribution of herpes simplex virus type 1 and varicella zoster virus in ganglia of the human head and neck. J Infect Dis. 2009;200:1901–6.CrossRefPubMedCentralPubMedGoogle Scholar
  5. 5.
    Yamamoto Y, Hill JM. HSV-1 recovery from ocular tissues after viral inoculation into the superior cervical ganglion. Invest Ophthalmol Vis Sci. 1986;27:1447–52.PubMedGoogle Scholar
  6. 6.
    Shimomura Y, Mori Y, Inoue Y, Kiritooshi A, Ohashi Y, Manabe R. Herpes simplex virus latency in human cornea. Jpn J Ophthalmol. 1993;37:318–24.PubMedGoogle Scholar
  7. 7.
    Kaye SB, Lynas C, Patterson A, Risk JM, McCarthy K, Hart CA. Evidence for herpes simplex viral latency in the human cornea. Br J Ophthalmol. 1991;75:195–200.CrossRefPubMedCentralPubMedGoogle Scholar
  8. 8.
    Openshaw H, McNeill JI, Lin XH, Niland J, Cantin EM. Herpes simplex virus DNA in normal corneas: persistence without viral shedding from ganglia. J Med Virol. 1995;46:75–80.CrossRefPubMedGoogle Scholar
  9. 9.
    Morris DJ, Cleator GM, Klapper PE, Cooper RJ, Biney EO, Dennett C, et al. Detection of herpes simplex virus DNA in donor cornea culture medium by polymerase chain reaction. Br J Ophthalmol. 1996;80:654–7.CrossRefPubMedCentralPubMedGoogle Scholar
  10. 10.
    Kaye SB, Baker K, Bonshek R, Maseruka H, Grinfeld E, Tullo A, et al. Human herpesviruses in the cornea. Br J Ophthalmol. 2000;84:563–71.CrossRefPubMedCentralPubMedGoogle Scholar
  11. 11.
    Fukuda M, Deai T, Higaki S, Hayashi K, Shimomura Y. Presence of a large amount of herpes simplex virus genome in tear fluid of herpetic stromal keratitis and persistent epithelial defect patients. Semin Ophthalmol. 2008;23:217–20.CrossRefPubMedGoogle Scholar
  12. 12.
    Gordon YJ, Romanowski E, Araullo-Cruz T, McKnight JL. HSV-1 corneal latency. Invest Ophthalmol Vis Sci. 1991;32:663–5.PubMedGoogle Scholar
  13. 13.
    Kennedy DP, Clement C, Arceneaux RL, Bhattacharjee PS, Huq TS, Hill JM. Ocular herpes simplex virus type 1: is the cornea a reservoir for viral latency or a fast pit stop? Cornea. 2011;30:251–9.CrossRefPubMedCentralPubMedGoogle Scholar
  14. 14.
    Stevens JG, Wagner EK, Devi-Rao GB, Cook ML, Feldman LT. RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons. Science. 1987;27(235):1056–9.CrossRefGoogle Scholar
  15. 15.
    Kent JR, Kang W, Miller CG, Fraser NW. Herpes simplex virus latency-associated transcript gene function. J Neurovirol. 2003;9:285–90.CrossRefPubMedGoogle Scholar
  16. 16.
    Bertke AS, Patel A, Imai Y, Apakupakul K, Margolis TP, Krause PR. Latency-associated transcript (LAT) exon 1 controls herpes simplex virus species-specific phenotypes: reactivation in the guinea pig genital model and neuron subtype-specific latent expression of LAT. J Virol. 2009;83:10007–15.CrossRefPubMedCentralPubMedGoogle Scholar
  17. 17.
    Shimomura Y, Higaki S. The kinetics of herpes virus on the ocular surface and suppression of its reactivation. Cornea. 2011;30(Suppl 1):S3–7.CrossRefPubMedGoogle Scholar
  18. 18.
    Higaki S, Watanabe K, Itahashi M, Shimomura Y. Cyclooxygenase (COX)-inhibiting drug reduces HSV-1 reactivation in the mouse eye model. Curr Eye Res. 2009;34:171–6.CrossRefPubMedGoogle Scholar
  19. 19.
    Kaufman HE, Azcuy AM, Varnell ED, Sloop GD, Thompson HW, Hill JM. HSV-1 DNA in tears and saliva of normal adults. Invest Ophthalmol Vis Sci. 2005;46:241–7.CrossRefPubMedCentralPubMedGoogle Scholar
  20. 20.
    Sawtell NM, Thompson RL, Stanberry LR, Bernstein DI. Early intervention with high-dose acyclovir treatment during primary herpes simplex virus infection reduces latency and subsequent reactivation in the nervous system in vivo. J Infect Dis. 2001;184:964–71.CrossRefPubMedGoogle Scholar
  21. 21.
    Luppi M, Barozzi P, Morris C, Maiorana A, Garber R, Bonacorsi G, et al. Human herpesvirus 6 latently infects early bone marrow progenitors in vivo. J Virol. 1999;73:754–9.PubMedCentralPubMedGoogle Scholar
  22. 22.
    Frenkel N, Schirmer EC, Wyatt LS, Katsafanas G, Roffman E, Danovich RM, et al. Isolation of a new herpesvirus from human CD4 + T cells. Proc Natl Acad Sci USA. 1990;87:748–52.CrossRefPubMedCentralPubMedGoogle Scholar

Copyright information

© Japanese Ophthalmological Society 2015

Authors and Affiliations

  • Shiro Higaki
    • 1
    Email author
  • Masahiko Fukuda
    • 2
  • Yoshikazu Shimomura
    • 2
  1. 1.Department of OphthalmologyKinki University Sakai HospitalSakaiJapan
  2. 2.Department of OphthalmologyKinki University Faculty of MedicineOsaka-SayamaJapan

Personalised recommendations